OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 12
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 12
Showing 12 citing articles:
Structure–Activity Relationship of Ciprofloxacin towards S-Spike Protein of SARS-CoV-2: Synthesis and In-Silico Evaluation
Sahil Kumar, Papiya Dey, Arup Kumar Pathak, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Sahil Kumar, Papiya Dey, Arup Kumar Pathak, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses
Theocharis Tsoleridis, Chengcheng Fan, Emily J. Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Theocharis Tsoleridis, Chengcheng Fan, Emily J. Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Identification of antibody-resistant SARS-CoV-2 mutants via N4-Hydroxycytidine mutagenesis
Priya Kumar, Xiaoxiao Zhang, Rahul Shaha, et al.
Antiviral Research (2024) Vol. 231, pp. 106006-106006
Open Access | Times Cited: 2
Priya Kumar, Xiaoxiao Zhang, Rahul Shaha, et al.
Antiviral Research (2024) Vol. 231, pp. 106006-106006
Open Access | Times Cited: 2
Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 1
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 1
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single center study.
Ivan Gentile, Giulio Viceconte, F. M. Cuccurullo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Ivan Gentile, Giulio Viceconte, F. M. Cuccurullo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Respiratory mucosal administration of DNA aptamer nanomaterials protects against antigenically diverse SARS-CoV-2 variants
Michael R. D’Agostino, Jiuxing Li, Zijie Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Michael R. D’Agostino, Jiuxing Li, Zijie Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation
Rosaria De Filippi, Gianpaolo Marcacci, Sabrina Amelio, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access
Rosaria De Filippi, Gianpaolo Marcacci, Sabrina Amelio, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access
Production of a monoclonal antibody targeting the SARS-CoV-2 Omicron spike protein and analysis of SARS-CoV-2 Omicron mutations related to monoclonal antibody resistance
Jinsoo Kim, Suyeon Kim, Sangkyu Park, et al.
Microbes and Infection (2024), pp. 105461-105461
Closed Access
Jinsoo Kim, Suyeon Kim, Sangkyu Park, et al.
Microbes and Infection (2024), pp. 105461-105461
Closed Access
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study
Ivan Gentile, Giulio Viceconte, F. M. Cuccurullo, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access
Ivan Gentile, Giulio Viceconte, F. M. Cuccurullo, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access
The Ability of Combined Flavonol and Trihydroxyorganic Acid to Suppress SARS-CoV-2 Reproduction
Andrey Bogoyavlenskiy, Pavel Alexyuk, Madina Alexyuk, et al.
Viruses (2024) Vol. 17, Iss. 1, pp. 37-37
Open Access
Andrey Bogoyavlenskiy, Pavel Alexyuk, Madina Alexyuk, et al.
Viruses (2024) Vol. 17, Iss. 1, pp. 37-37
Open Access
